↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Book
  • The PIV Blog
  • PIV Data
    • Get Access
Home→gregoryglass

gregoryglass

Profile picture of gregoryglass

@gregoryglass

Active 7 months, 2 weeks ago
  • Activity
  • Profile
  • Forums
  • Personal
  • Mentions
  • Favorites

Member Activities

RSS Feed

Loading the member’s updates. Please wait.

    Login

    Log In

    Latest updates

    Ingrezza®(valbenazine) Capsules
    Annual Sales $993M
    Company NEUROCRINE
    Date of First Filing April 12, 2021

    Paragraph IV Applicant: Lupin
    Case Name: NEUROCRINE BIOSCIENCES INC v. LUPIN LIMITED et al
    Court/Case #: Delaware District Court (dedc) 1:2021cv01042
    Date Filed: 7/16/21
    Judge:
    Product Strength: 40 mg and 80 mg
    Litigated…Read more

    Profile picture of parryashford 1 week ago

    Tymlos®(abaloparatide) Injection
    Annual Sales
    Company ELI LILLY
    Date of First Filing Not applicable

    Paragraph IV Applicant: Radius Health
    Case Name: ELI LILY AND COMPANY v. RADIUS HEALTH INC
    Court/Case #: Delaware District Court (dedc) 1:2021cv01003
    Date Filed: 7/8/21
    Judge: Connolly
    Product Strength: 3.12mg/1.56mL (2mg/mL);…Read more

    Profile picture of parryashford 2 weeks, 3 days ago

    Austedo®(deutetrabenazine) Tablets
    Annual Sales $134M
    Company TEVA
    Date of First Filing April 5, 2021

    Paragraph IV Applicant: Aurobindo
    Case Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC et al AUROBINDO PHARMA LTD et al
    Court/Case #: New Jersey District Court (njdc) 3:2021cv13240
    Date Filed: 7/1/21
    Judge: Wolfson
    Product…Read more

    Profile picture of parryashford 3 weeks ago
    The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2021
    ↑